Orforglipron
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 600
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.